Search by Medical Condition
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for Osteogenesis Imperfecta
- A First-in-Human Study Evaluating AGA2115 in Adult Healthy Volunteers
- Study to Evaluate Efficacy and Safety of Romosozumab Compared With Bisphosphonates in Children and Adolescents With Osteogenesis Imperfecta
- Setrusumab vs Bisphosphonates in Subjects 2 to <5 Years of Age With Osteogenesis Imperfecta
- Mesenchymal Cell Therapy in Osteogenesis Imperfecta (OI)
- Tranexamic Acid During Telescoping Nail Application In Osteogenesis Imperfecta
- Single Ascending Dose Study of SAR439459 in Adults With Osteogenesis Imperfecta (OI)
- Study to Evaluate Romosozumab in Children and Adolescents With Osteogenesis Imperfecta
- Effects of Bisphosphonates on OI-Related Hearing Loss
- Treatment of Osteogenesis Imperfecta With Parathyroid Hormone and Zoledronic Acid
- Open-label Extension Denosumab Study in Children and Young Adults With Osteogenesis Imperfecta
- An Exploratory Study of BPS804 Treatment in Adult Patients With Type I, III or IV Osteogenesis Imperfecta
- Do Bisphosphonates Alter the Skeletal Response to Mechanical Stimulation in Children With Osteogenesis Imperfecta?
- A Study in Adult Patients With Type I, III or IV Osteogenesis Imperfecta Treated With BPS804
- Safety of Fresolimumab in the Treatment of Osteogenesis Imperfecta
- Multicenter,Single-arm Study to Evaluate Efficacy, Safety, & Pharmacokinetics of Denosumab in Children w/ OI
- Efficacy and Safety of Alendronate in Chinese Children or Adolescents With Osteogenesis Imperfecta
- Translational Therapy in Patients With Osteogenesis Imperfecta - A Pilot Trial on Treatment With the Rankl-Antibody Denosumab
- The Effect of Treatment With Teriparatide and Zoledronic Acid in Patients With Osteogenesis Imperfecta
- Safety, Pharmacokinetics and Pharmacodynamics of BPS804 in Osteogenesis Imperfecta
- Trial of Lithium Carbonate for Treatment of Osteoporosis-pseudoglioma Syndrome
- An Efficacy and Safety Trial of Intravenous Zoledronic Acid in Infants Less Than One Year of Age, With Severe Osteogenesis Imperfecta
- Treatment of Severe Osteogenesis Imperfecta by Allogeneic Bone Marrow Transplantation
- Prevention of Post Operative Bone Loss in Children
- Bisphosphonate Therapy for Osteogenesis Imperfecta
- Study of Teriparatide (FORTEO) to Treat Adults With Osteogenesis Imperfecta
- Zoledronic Acid in Children (1 -17 Years) With Severe Osteogenesis Imperfecta
- Safety and Efficacy of Risedronate in the Treatment of Osteogenesis Imperfecta in Children
- Bisphosphonate Treatment of Osteogenesis Imperfecta
- Pamidronate to Treat Osteogenesis Imperfecta in Children
- Growth Hormone Therapy in Osteogenesis Imperfecta